SE7706520L - Guanidinderivat - Google Patents

Guanidinderivat

Info

Publication number
SE7706520L
SE7706520L SE7706520A SE7706520A SE7706520L SE 7706520 L SE7706520 L SE 7706520L SE 7706520 A SE7706520 A SE 7706520A SE 7706520 A SE7706520 A SE 7706520A SE 7706520 L SE7706520 L SE 7706520L
Authority
SE
Sweden
Prior art keywords
lower alkyl
represent
halogen
trifluoromethyl
represent hydrogen
Prior art date
Application number
SE7706520A
Other languages
English (en)
Other versions
SE424861B (sv
Inventor
T J Ward
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB23331/76A external-priority patent/GB1530675A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of SE7706520L publication Critical patent/SE7706520L/sv
Publication of SE424861B publication Critical patent/SE424861B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7706520A 1976-06-05 1977-06-03 Forfarande att framstella nya terapeutiskt aktiva derivat av guanidin innehallande en pyrrol-, pyrrolin- eller pyrrolidinrest SE424861B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23331/76A GB1530675A (en) 1976-06-05 1976-06-05 Guanidine derivatives
GB305677 1977-01-26

Publications (2)

Publication Number Publication Date
SE7706520L true SE7706520L (sv) 1978-01-20
SE424861B SE424861B (sv) 1982-08-16

Family

ID=26237989

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706520A SE424861B (sv) 1976-06-05 1977-06-03 Forfarande att framstella nya terapeutiskt aktiva derivat av guanidin innehallande en pyrrol-, pyrrolin- eller pyrrolidinrest

Country Status (15)

Country Link
US (1) US4140793A (sv)
JP (1) JPS52151161A (sv)
AU (1) AU509883B2 (sv)
CA (1) CA1070691A (sv)
CH (1) CH641159A5 (sv)
CY (1) CY1130A (sv)
DE (1) DE2724989A1 (sv)
DK (1) DK248177A (sv)
FR (1) FR2353530A1 (sv)
HK (1) HK57981A (sv)
IE (1) IE45198B1 (sv)
KE (1) KE3170A (sv)
MY (1) MY8200180A (sv)
NL (1) NL7706173A (sv)
SE (1) SE424861B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
GB1588096A (en) * 1978-05-20 1981-04-15 Wyeth & Bros Ltd John Pyrrole derivatives
US4332822A (en) * 1980-02-05 1982-06-01 John Wyeth & Brother Limited Guanidine derivatives
FR2490026A1 (fr) * 1980-09-09 1982-03-12 Thomson Csf Antenne reseau non dispersive et son application a la realisation d'une antenne a balayage electronique
US4563475A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Guanidine derivatives for treating gastrointestinal motility dysfunction
JPH01106831U (sv) * 1988-01-08 1989-07-19
JPH0742036Y2 (ja) * 1988-06-22 1995-09-27 ダイキン工業株式会社 スポットエアコンのダクト取付構造
PE20060459A1 (es) * 2004-06-16 2006-05-30 Wyeth Corp DERIVADOS DE AMINO-5,5-DIFENILIMIDAZOLONA COMO INHIBIDORES DE LA ß-SECRETASA
AU2005264917A1 (en) * 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of B-secretase
CN101103034A (zh) * 2005-01-14 2008-01-09 惠氏公司 抑制β-分泌酶的氨基-咪唑酮
WO2006083760A1 (en) * 2005-02-01 2006-08-10 Wyeth AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE
CN101146769A (zh) * 2005-02-14 2008-03-19 惠氏公司 作为β-分泌酶抑制剂的唑基酰基胍
WO2007005404A1 (en) * 2005-06-30 2007-01-11 Wyeth AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
TW200738683A (en) * 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
TW200730523A (en) * 2005-07-29 2007-08-16 Wyeth Corp Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
EP2256107A1 (en) * 2005-09-26 2010-12-01 Wyeth LLC Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
CN101360737A (zh) * 2005-12-19 2009-02-04 惠氏公司 2-氨基-5-哌啶咪唑酮化合物和其用于β分泌酶调节的用途
WO2007100536A1 (en) * 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) * 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
JP2010504326A (ja) * 2006-09-21 2010-02-12 ワイス エルエルシー β−セクレターゼを阻害するためのインドリルアルキルピリジン−2−アミン
PE20090160A1 (es) * 2007-03-20 2009-02-11 Wyeth Corp COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
PE20090617A1 (es) * 2007-03-23 2009-05-08 Wyeth Corp Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3189601A (en) * 1964-01-10 1965-06-15 Ciba Geigy Corp N, n-alkylene-imino-lower alkanoamidine compounds

Also Published As

Publication number Publication date
SE424861B (sv) 1982-08-16
FR2353530B1 (sv) 1981-07-17
CH641159A5 (de) 1984-02-15
DK248177A (da) 1977-12-06
KE3170A (en) 1981-12-18
NL7706173A (nl) 1977-12-07
AU2535677A (en) 1978-11-23
HK57981A (en) 1981-12-04
FR2353530A1 (fr) 1977-12-30
DE2724989A1 (de) 1977-12-15
JPS52151161A (en) 1977-12-15
CY1130A (en) 1982-02-19
IE45198L (en) 1977-12-05
IE45198B1 (en) 1982-07-14
AU509883B2 (en) 1980-05-29
MY8200180A (en) 1982-12-31
JPS613332B2 (sv) 1986-01-31
US4140793A (en) 1979-02-20
CA1070691A (en) 1980-01-29

Similar Documents

Publication Publication Date Title
SE7706520L (sv) Guanidinderivat
NL7610695A (nl) Piperidyl-triazinederivaten.
TR199801734T2 (xx) Yeni arilglisinamid t�revleri, �retim y�ntemleri.
NL7409439A (nl) Werkwijze voor het bereiden van tricyclisch gesubstitueerde aminoalkoholen en hun niet-toxi- sche zouten.
SE424323B (sv) Vissa angivna 3-alkoxi-benso-1,2,4-triaziner till anvendning som fungicideroch baktericider
ES2060607T3 (es) Piperazinas substituidas.
SE7514374L (sv) N-(1-substituerade-3-pyrrolidinyl)-1-naftalens och 4-kinonlinkarboxiamider
SE7811455L (sv) 2-imino-imidazolidin-derivat
YU45598B (sh) Bis-(piperazinil)-oz homopiperazinil)-alkani
SE387625B (sv) Sett for framstellning av foreningar med den allmenna formeln r'-c-c-r?722, varvid foreningar med den allmenna formeln r'-c-ch omsettes med foreningar med den allmenna formeln x-r'722, der x betecknar halogen
SE399424B (sv) Sett att framstella n-arylsulfonyl-n'-(3-azabicykloalkyl)karbamider med terapentiska egenskaper, speciellt hypoglycemisk verkan
SE7507039L (sv) Nya bensodiazepinderivat jemte sett for deras framstellning.
ES407816A1 (es) Metodo para producir derivados de benzodiazepina.
BE847361A (fr) Combinaison regulateur de temperature-thermostat de securite,
FR2344603A1 (fr) Derives du naphtolactame utilisables comme colorants
ES467449A1 (es) Un procedimiento para la preparacion de derivados de benza- mida.
SE7603637L (sv) Sett att framstella n-(polysackaridyl)-kveveheterocykler, isynnerhet av pyrimidin- eller pyrinbaser
ES390037A1 (es) Un procedimiento de preparacion de nuevas indaminas o salesde indaminas.
DK271075A (da) Derivater af alkylolerede amino-1,3,5-triaziner deres fremstilling og anvendelse
DK126194B (da) Fremstilling af 1,1'-disubstituerede-4,4'-bipyridyliumsalte.
AR217041A1 (es) Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil)
ES473737A1 (es) Procedimiento para la preparacion de triazapentadienos.
ES2043873T3 (es) Derivados de nicotil-piperacina, procedimiento de preparacion y utilizacion en terapeutica.
SE7910333L (sv) 3-hydroxu-1,4-bensodiazepin-2-oner
ES464480A1 (es) Procedimiento para preparar esteres de acidos bencenosulfonicos sustituidos.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7706520-9

Effective date: 19890725

Format of ref document f/p: F